Goldplat CEO Werner Klingenberg discusses dividend policy, share buybacks and the Kilimenpesa sale. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
explains why the shares have outperformed over the last month. i was hoping to add to my position on weakness but despite a lower ft100, these shares have stayed firm.
held the 200 day ma and then a great reaction off it later on. the 15 quid level takes you back as far as july last year. the next leg of the cyclical trade should see these make a new post covid high.
Good results (again!) Should return to pre Covid levels before too long.
Looks a very good set up on chart to rise a lot higher .
Very surprised that today's announcement in press that Govt is to increase defence spending by £16 billion has not impacted those shares most likely to be affected. I am buying Smiths Group and Meggitt today.
more of a dip ,had been hoping ,for move back upwards , how many who researching smin might be liking this lower share price better
still many share buys coming in ,sme liking this current price , have been watching covid test maker ncyt more recently with news on new test due ,like the potential here at smin ,in my view smin a share worth watching
after dip ,how many ,might be seeing ,a dip with share price as an opportunity
Stunning trading report. Not many companies will post increased revenue to 31st May 2020. good one to buy and tuck away for a couple of years.
UK's Smiths makes ventilator available to other producers
Sat, 21st Mar 2020 11:17Thomson Reuters
LONDON, March 21 (Reuters) - British technology firm Smiths
Group said it was making one of its ventilators
available for other manufacturers to produce, part of a
coordinated attempt to tackle a shortage of life-saving
equipment as coronavirus spreads.
The group's Smiths Medical unit was providing intellectual
property and advice to other companies to make its PARAPAC
Plus lightweight ventilators, and it was ramping up its own
production at its site in Luton, just north of London.
Smiths said it was also talking to contract manufacturers to
add production capacity in the United States and elsewhere.
"We are doing everything possible to substantially increase
production of our ventilators at our Luton site and worldwide,"
its chief executive, Andrew Reynolds Smith, said.
Smiths said it was working with suppliers to increase
production over the next two weeks.
Smiths is a member of one of three consortia of companies
set up by Britain's government to speed up production of
The three teams are led by aerospace engineer Meggitt
and carmakers McLaren and Nissan. European
planemaker Airbus has offered help with 3D technology
and facilities if other companies need it.
(Writing by William Schomberg, editing by Ed Osmond)
aint got time for a indepth research. only put £400 inno.
its just dropped like all others from 16 quid
You do realise that they are demerging the medical equipment business after years of poor performance?
for a medical equipment bisness. should go to 12 pounds easily
I just bought a load
Worth buying at this level I feel
too cheap to ignore right now. Its earnings multiple is reasonable and its dividend is decent, but what particularly draws me to the stock is its discount to the sum of the value of the group’s parts.
Dated 21st SEPTEMBER 2018
Today’s full-year results from Smiths show a mixed picture. Currency headwinds caused revenue to fall by 2% to £3,213m last year. And headline pre-tax profit fell by 8% to £487m.
However, the company says that on an underlying basis — excluding various one-off factors such as acquisitions and disposals — earnings per share of 90.7p represent a 4% increase on the previous year.
I’m normally cautious about such wide-ranging adjustments, but in this case I think they are fair. Analysts expect underlying earnings to rise by about 10% this year, and I don’t see any reason to doubt this.
EX DIVIDEND ON THURSDAY 18th OCTOBER 2018 AMOUNT PAYABLE IS 30.75p PAYED ON 16th NOVEMBER
SO YOU HAVE UNTIL WEDNESDAY 4.30 PM IF YOU WAN'T THE DIVIDEND
Now steady with potential for a slow rebound?
This is very cheap - if you look at the value of medical division you dont get enough for the rest. More here: https://deepvalueinvestments.wordpress.com/2015/12/28/smiths-industries-large-conglomerate-discount/
Smiths Group PLC Thu 17 December 2015 A A A Recommendation type: Income Daniel Liberto A much-needed pension shake-up and better trading prospects across some of its core divisions suggest Smiths' (SMIN) prospects could be turning up as its new boss gets to work. Shares in the sprawling engineering conglomerate have tanked in the past two years, as difficult end markets and a big pension deficit proved hard to manage. But with these issues now easing - and the shares languishing on a forward PE multiple of 11 times - the high-yielding maker of everything from industrial valves to X-ray scanners suddenly looks attractive and raises prospects that a long-mooted break-up could finally be in prospect. News that Smiths has tidied up its retirement obligations represents a major breakthrough which has turned us from sellers of the stock to buyers. A recent valuation of the engineer's UK scheme put the group's actuarial deficit at Â£285m, down Â£250m since the last valuation in 2012. This means annual contributions will fall from Â£60m to Â£24m by 2017, freeing up Â£36m of free cash flow a year, which compares with free cash flow of Â£158m in 2015. Â Management plans to use these extra funds to invest in the business and grow the dividend, which is forecast to provide investors with a handsome yield of 4.4 per cent this year, rising to 4.6 per cent. Expectations of dividend growth are also underpinned by solid cover, which is expected to remain above two times in coming years. Resolving the pension deficit could also trigger the long-awaited break-up of the company. While some investors say the group's diversified portfolio leaves it better protected than many industrial peers, others complain that Smiths' disparate collection of companies enjoy scant synergies. The latter sentiment prompted previous chief executive Philip Bowman to explore ways to offload some units but the pension mess and other issues such as asbestos liabilities thwarted those attempts. With the pension issue cleared, new boss Andrew Reynolds Smith may re-evaluate the potential to sell some assets. He is expected to update investors on strategy during the first half of next year. Having previously held a number of senior positions at GKN (GKN), the new chief's engineering background should also help to drive improvements across the business. Better trading in the three months to November, together with renewed hope that some of the core businesses are finally turning a corner, could assist with these efforts. The medical arm, which accounted for 29 per cent of last year's sales and 30 per cent of profit, is expected to benefit from investments made in new product launches. Meanwhile, the detection unit, which makes high-tech radars and accounted for 16 per cent of sales and 10 per cent of profit last year, is expected to benefit from more stringent regulatory standards for screening i
Airport x-ray machine-to-mechanical seals conglomerate Smiths Group (SMIN) had its best day in years this week. The shares rocketed 10%, despite supplying parts to the struggling oil industry and a terrible 2015 for the electronics division. New chief Andy Reynolds Smith has just reported a "resilient" first-quarter and said expectations for the full-year remain broadly unchanged. What got investors really excited, however, was news that the firm is tackling its huge pension deficit. At the end of March, the pension scheme's deficit was £285 million, about £250 million lower than the previous triennial valuation in 2012. A deal with trustees to slash annual cash contributions to the scheme will free up £36 million a year. Finance chief Chris O'Shea says Smiths will use the extra cash to pump funds back into the business, make acquisitions, and keep growing the dividend. And top brass are backing themselves to do big things by snapping up over £1.2 million worth of Smiths Group shares. Reynolds Smith opened his account by buying 100,000 shares at 992.75p each, while Chris O'Shea also made his first share purchase: he and his wife loaded up on 20,000 shares at 999.24p a throw. Chairman Sir George Buckley also got involved, doubling his stake with the acquisition of 5,000 shares at a sterling equivalent of about 996p. Not everyone's so bullish, however. Sanjay Jha at Panmure Gordon says 'sell' and is calling the shares down to 850p. The pensions trick means total free cash flow is now more likely to cover an unchanged dividend in 2017 and 2018, but it won’t be enough to do the extra investing that O'Shea claims it will, reckons Jha. Downgraded estimates for the next three years put Smiths on a forward price/earnings (PE) multiple of 14-16 times.
Smiths Group pension affects fair value Pension ‘perplexities’ at engineering company Smiths Group (SMIN) have the ability to move the share price by 5% either way. Deutsche Bank analyst Stephen Stakhiv retained his ‘buy’ recommendation and target price of £12.50 on the shares, which inched 0.6% higher to 995p yesterday. ‘The key issue to emerge from Smiths Q1 interim management statement was on pensions…the pensions issues…have the potential to change fair value estimates by 5% to the upside or downside,’ he said. Stakhiv said the issues lay around the valuation of the Smiths Group pension scheme as the actuarial calculation shows the company’s pension liability fell £250 million since July but Stakhiv said the reduction was closer to £100 million. However, ‘£130 million of cash will be freed over the next five years because of the ongoing lower cash contributions needed and the elimination of payments in escrow’.
Smiths Group became one of the biggest laggards. Despite announcing a material change in its pension fund structure, RBC Capital Markets and Societe Generale lowered its target price. Andrew Carter, of RBC, cautioned investors about the “significant uncertainty” which surrounds the group’s oil and gas end markets. Shares tumbled 30.5p to 989.5p.